Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

KOLSTER METHODS

K-Number: K935820 · 1994-07-19

Decision Date1994-07-19
Product CodeHGH
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

KOLSTER METHODS is the device name listed in this FDA 510(k) record. The listed applicant is Kolster Methods. It received FDA 510(k) clearance on 1994-07-19 under 510(k) number K935820. The device is classified under product code HGH. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the KOLSTER METHODS?

KOLSTER METHODS is a medical device that received FDA 510(k) clearance on 1994-07-19. The listed applicant is Kolster Methods. The 510(k) number is K935820.

When did KOLSTER METHODS receive FDA 510(k) clearance?

KOLSTER METHODS received FDA 510(k) clearance on 1994-07-19, under 510(k) number K935820.

Who is the listed applicant for KOLSTER METHODS?

The FDA 510(k) record lists Kolster Methods as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for KOLSTER METHODS?

The FDA product code for KOLSTER METHODS is HGH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Kolster Methods as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: HGH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑